Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.66 |
| ▸ | ACHE | P22303 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | NSD2 | O96028 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13003482 | 0.92 | ELANE (0.61) | ELANEACHEKMT2ALMNAALDH1A1 | |
| SCHEMBL27581241 | 0.88 | ELANE (0.59) | ELANEMEN1KMT2ALMNAFFAR1 | |
| SCHEMBL17138144 | 0.84 | ALDH1A1 (0.51) | ELANEACHEMEN1KMT2ALMNA | |
| SCHEMBL17138199 | 0.83 | ELANE (0.48) | ELANEACHEMEN1KMT2ALMNA | |
| SCHEMBL10483715 | 0.80 | ELANE (1.00) | ELANEACHEFFAR1ESR1HIF1A | |
| SCHEMBL9724815 | 0.79 | ELANE (0.61) | ELANEMEN1KMT2ALMNAFFAR1 | |
| SCHEMBL9724817 | 0.79 | ELANE (0.61) | ELANEMEN1KMT2ALMNAFFAR1 | |
| SCHEMBL9724797 | 0.79 | ELANE (0.57) | ELANEMEN1KMT2AFFAR1ESR1 | |
| SCHEMBL10782553 | 0.77 | ACHE (0.71) | ELANEACHEMEN1KMT2ALMNA | |
| SCHEMBL17138172 | 0.77 | ACHE (0.42) | ELANEACHEMEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150283051-A1 | DERIVATIVE OF NOVEL POLYHYDROXY AROMATIC COMPOUND AND USE THEREOF | RNS CO.,LTD. (KR) | 2015-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150283051-A1 | DERIVATIVE OF NOVEL POLYHYDROXY AROMATIC COMPOUND AND USE THEREOF | HRH3, CBR3, H1-0 | ELANE 1714/4885ACHE 2498/4885MEN1 4684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.